ArticleInternational journal of molecular sciences2026
Terminal V5 Tagging of All Four Newcastle Disease Virus Structural Proteins Is Compatible with Particle Formation in Sf9 Cells.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Newcastle disease virus-like particles (NDVLPs) assemble from the matrix (M), nucleoprotein (NP), fusion (F) and hemagglutinin-neuraminidase (HN) proteins. Terminal epitope tags make these proteins easy to detect but may interfere with assembly, and it is not well-documented how much terminal modification the four proteins tolerate. Eight pFastBac Dual donor plasmids were used to generate recombinant baculoviruses, and twelve NDVLP variants were produced in Sf9 cells and purified by sucrose gradient ultracentrifugation. Particle-like structures were recovered from all twelve preparations. Western blotting confirmed production of the native and V5-tagged proteins and their co-purification in the particle fractions; transmission electron microscopy showed enveloped, roughly spherical particles with measured diameters of 55 to 150 nm (median 90 nm) in every preparation, similar in appearance to native NDV. Particles of a similar size were also present in the beta-glucuronidase control preparation, so the assignment of the particles rests on the protein composition of the fractions rather than on morphology alone. Particles formed regardless of which structural protein carried the tag, including a variant in which all four proteins were tagged simultaneously. Under the conditions tested, 19-residue terminal insertions were compatible with NDVLP recovery at each of the four positions examined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.